rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAATCACTAGCGATCTACAATGAGCAGTTCTTCGGGCCA	CASSQSLAIYNEQFF	In	VDJ	1	25	0.002585582790360947	0.0033724537973829757	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	3	6	3	2	2	29	44	53	46	55						01,02							Vb 16	CASSQSLAIYNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01	TCRBJ02-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATTCCAGTCTTACCTACGAGCAGTACTTCGGGCCG	CASSQDSSLTYEQYF	In	VDJ	1	38	0.00393008584134864	0.005126129772022123	45	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	5	2	3	5	29	46	52	49	57													Vb 16	CASSQDSSLTYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAACGAGTCGGGGCTGGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	45	0.004654049022649705		46	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-01	01	2	7	0	6	7	3	29	44	56	51	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01		TCRBJ02-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCTGGCTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	61	0.006308822008480711		40	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	9	0	3	3	1	29	46	52	49	53													Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTGAGGACAGGGGACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	66	0.006825938566552901		47	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	1	2	2	3	1	29	45	57	48	58													Vb 16	X+TCRBV14-01+TCRBJ02-05	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-05*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATAGGTAGGACTACCGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	2	74	0.007653325059468404		49	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	1	9	5	6	3	29	46	58	52	61						01,02							Vb 16	X+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01	TCRBD02-01	TCRBJ02-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCTGGACCTCGGGGATACGCAGTATTTTGGCCCA	CASSLDLGDTQYF	In	VDJ	1	19	0.00196504292067432	0.0025630648860110617	39	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-03	01	6	1	7	6	3	6	24	35	42	38	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDLGDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01		TCRBJ02-03*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGAACTAGCGGTGTACAATGAGCAGTTCTTCGGGCCA	CASSVELAVYNEQFF	In	VDJ	1	20	0.002068466232288758	0.0026979630379063806	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	3	5	4	5	2	24	36	49	41	51						01,02								CASSVELAVYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTGGTCGGACGGCGAAGAGACCCAGTACTTCGGGCCA	CASSWSDGEETQYF	In	VDJ	3	129	0.013341607198262488	0.017401861594496155	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-05	01	5	1	7	3	5	4	24	36	45	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWSDGEETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01		TCRBJ02-05*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAGTTGGGTACATAATGAACACTGAAGCTTTCTTTGGACAA	CASSLVGYIMNTEAFF	In	VDJ	1	23	0.0023787361671320714	0.003102657493592338	48	TCRBV07	TCRBV07-05	01				TCRBJ01	TCRBJ01-01	01	0	0	9	0	2	7	19	35	40	37	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVGYIMNTEAFF+TCRBV07-05+TCRBJ01-01	TCRBV07-05*01		TCRBJ01-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAGCTGACGGGGCAGATACGCAGTATTTTGGCCCA	CASSEADGADTQYF	In	VDJ	2	68	0.007032785189781777	0.009173074328881694	42	TCRBV06	TCRBV06-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	8	3	4	3	0	23	40	-1	43	48														CASSEADGADTQYF+TCRBV06-01+TCRBJ02-03	TCRBV06-01*01	TCRBD02-01*01	TCRBJ02-03*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCAGATATAGTTTGCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	13	0.0013445030509876927		53	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-06	01	5	3	6	5	13	5	23	35	51	48	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV01-01+TCRBJ02-06	TCRBV01-01*01		TCRBJ02-06*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGATAGGCAGGGGATCGCAAAACTATGGCTACACCTTCGGTTCG		Out	VDJ	8	323	0.03340572965146344		52	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	2	2	4	7	23	40	50	44	57														X+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-02*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCAAGACTAGCGGGAGTTACGAGCAGTACTTCGGGCCG	CASSKTSGSYEQYF	In	VDJ	1	29	0.002999276036818699	0.003912046404964252	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	2	2	4	2	1	19	31	45	33	46													Vb 5.1	CASSKTSGSYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-07*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
GAGGGACTCAGCCGTGTATCTCTACACCAGCAGGGCTGGGGGTGTGCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	15	0.0015513496742165685		53	TCRBV17	TCRBV17-01	01				TCRBJ02	TCRBJ02-06	01	10	4	3	5	4	20	22	26	35	30	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV17-01+TCRBJ02-06	TCRBV17-01*01		TCRBJ02-06*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
GAGGGACTCAGCCGTGTATCTCTACAGTAGCGGATAAACTTTCTGGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	49	0.005067742269107457		52	TCRBV17	TCRBV17-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	1	6	5	11	5	22	33	49	44	54														X+TCRBV17-01+TCRBJ02-06	TCRBV17-01*01	TCRBD01-01*01	TCRBJ02-06*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGAAGGGCGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASRRAGTGELFF	In	VDJ	1	12	0.0012410797393732546	0.0016187778227438284	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	7	3	5	4	0	25	36	-1	40	46													Vb 3	CASRRAGTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-02*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGGGGACAGGGCCAAAACATTCAGTATTTCGGCGCC	CASRGQGQNIQYF	In	VDJ	1	13	0.0013445030509876927	0.0017536759746391475	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	0	3	19	0	16	25	-1	45	36	61													Vb 3	CASRGQGQNIQYF+TCRBV28-01+TCRBJ02-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-04*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGATCTACAGGGCACACTGAAGCTTTCTTTGGACAA	CASRSTGHTEAFF	In	VDJ	1	19	0.00196504292067432	0.0025630648860110617	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	3	3	4	1	25	36	46	40	47													Vb 3	CASRSTGHTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCAGGGGACTCTACGAGCAGTACTTCGGGCCG	CASSSRGLYEQYF	In	VDJ	1	24	0.0024821594787465093	0.003237555645487657	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	4	4	2	3	1	3	25	38	45	39	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSSRGLYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTTTCAGGGCGTATGGCTACACCTTCGGTTCG	CASSFFRAYGYTF	In	VDJ	1	25	0.002585582790360947	0.0033724537973829757	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	3	5	3	2	25	39	47	42	49													Vb 3	CASSFFRAYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTAGGGACAGCCATTAACTACGAGCAGTACTTCGGGCCG	CASSLGTAINYEQYF	In	VDJ	1	26	0.0026890061019753855	0.003507351949278295	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	3	3	7	25	37	47	40	54													Vb 3	CASSLGTAINYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGGGGGCCGAGGCTCTGGAAACACCATATATTTTGGAGAG	CASSLGGRGSGNTIYF	In	VDJ	1	27	0.0027924294135898233	0.003642250101173614	48	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-03	01	3	6	0	0	1	5	25	39	46	40	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLGGRGSGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01		TCRBJ01-03*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGTGGGGGCATCGCTGGAAACACCATATATTTTGGAGAG	CASGGIAGNTIYF	In	VDJ	1	42	0.004343779087806391	0.0056657223796034	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	9	6	0	2	1	4	25	33	40	34	44													Vb 3	CASGGIAGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCTCTGACAGGGAGGGGAGAAAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	68	0.007032785189781777		50	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	4	2	3	3	4	9	25	38	49	42	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGCAGGTATTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLAGISNQPQHF	In	VDJ	2	84	0.008687558175612783	0.0113314447592068	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	4	0	1	3	25	40	45	41	48													Vb 3	CASSLAGISNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCAAATGCAGGGTATAGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSQMQGIGTGELFF	In	VDJ	24	991	0.10249250180990796	0.13368406852826117	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	3	4	6	6	25	37	48	43	54													Vb 3	CASSQMQGIGTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTGACAGGGGAAGGTCGGACCGATGAAAAACTGTTTTTTGGCAGT	CSVVTGEGRTDEKLFF	In	VDJ	1	28	0.002895852725204261	0.003777148253068933	48	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	2	2	6	1	12	25	35	44	36	56													Vb 4	CSVVTGEGRTDEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCGGGCAGGGACACAGATACGCAGTATTTTGGCCCA	CSAGRDTDTQYF	In	VDJ	1	59	0.006101975385251836	0.007958990961823823	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	4	3	2	4	1	25	32	41	36	42													Vb 4	CSAGRDTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-03*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCACCAGGACTAGCGGAGATCGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASTRTSGDRSYNEQFF	In	VDJ	1	14	0.0014479263626021306	0.0018885741265344666	51	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	7	1	5	0	3	6	26	36	49	39	55		TCRBV06-04,TCRBV06-07				01,02								CASTRTSGDRSYNEQFF+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
GGRGGACTYSGCYGTGTATCTCTGTGCCAGCAGCTTAGAAGTATTGGATGAGCAGTTCTTCGGGCCA	CASSLEVLDEQFF	In	VDJ	1	32	0.0033095459716620127	0.004316740860650209	39	TCRBV07	unresolved		unresolved			TCRBJ02	TCRBJ02-01	01	1	0	10	8	7	0	20	36	-1	43	45		TCRBV07-01,TCRBV07-08		TCRBD01,TCRBD02										CASSLEVLDEQFF+TCRBV07-X+TCRBJ02-01	unresolved	unresolved	TCRBJ02-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGCCGAGGACAGAACTATGGCTACACCTTCGGTTCG	CASSRGQNYGYTF	In	VDJ	1	32	0.0033095459716620127	0.004316740860650209	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	5	2	4	0	23	34	-1	38	44		TCRBV06-04,TCRBV06-08												CASSRGQNYGYTF+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTTTAGCGGGACAAACGAACACTGAAGCTTTCTTTGGACAA	CASSLAGQTNTEAFF	In	VDJ	1	34	0.0035163925948908884	0.004586537164440847	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	5	3	1	0	5	23	-1	44	36	49		TCRBV06-05,TCRBV06-06,TCRBV06-08												CASSLAGQTNTEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTCCGGGACTTGAGGACAATGAGCAGTTCTTCGGGCCA	CASSPGLEDNEQFF	In	VDJ	3	142	0.014686110249250182	0.0191555375691353	42	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	10	5	2	5	23	35	43	37	48		TCRBV10-01,TCRBV10-02				01,02								CASSPGLEDNEQFF+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGGTTTGTCGGAGAGAGATGGCTACGAGCAGTACTTCGGGCCG	XASSQGLSERDGYEQYF	In	VDJ	1	12	0.0012410797393732546	0.0016187778227438284	51	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	10	2	3	7	8	22	38	49	45	57													Vb 7.1	XASSQGLSERDGYEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-07*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCAAGGACAGGAATGAAGCTTTCTTTGGACAA	CASSKDRNEAFF	In	VDJ	1	13	0.0013445030509876927	0.0017536759746391475	36	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	4	7	2	2	23	35	44	37	46													Vb 7.1	CASSKDRNEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAGCCCGGGACTAGCGGGAAAGGGGGAGAGACCCAGTACTTCGGGCCA	CASSQPGTSGKGGETQYF	In	VDJ	1	22	0.0022753128555176336	0.0029677593416970187	54	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	0	3	4	4	7	23	37	54	41	61													Vb 7.1	CASSQPGTSGKGGETQYF+TCRBV04-01+TCRBJ02-05	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-05*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATTATGGAGGATCTGAAGCTTTCTTTGGACAA	CASSQDYGGSEAFF	In	VDJ	1	47	0.004860895645878581	0.006340213139079995	42	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	10	1	6	4	2	23	40	49	44	51													Vb 7.1	CASSQDYGGSEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01	TCRBD02-01*02	TCRBJ01-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CRRRRGACTCAGCCSTGTATCTCTRCGCCAGCAGCCAAGACGCGGGACAGTACGAAAAACTGTTTTTTGGCAGT	XASSQDAGQYEKLFF	In	VDJ	10	436	0.04509256386389492	0.0588155942263591	45	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	0	5	8	3	3	22	39	49	42	52													Vb 7.1	XASSQDAGQYEKLFF+TCRBV04-01+TCRBJ01-04	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-04*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGGACTAGCCGGGACCATGTAGTCTTCGGGCCA	CASRTSRDHVVF	In	VDJ	1	12	0.0012410797393732546	0.0016187778227438284	36	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	2	7	17	0	13	23	-1	41	34	54						01,02							Vb 12	CASRTSRDHVVF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01	TCRBJ02-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCACTAGTGGGCGGGAGCGATCCTACAATGAGCAGTTCTTCGGGCCA	CASTSGRERSYNEQFF	In	VDJ	1	12	0.0012410797393732546	0.0016187778227438284	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	9	7	2	1	9	3	27	35	51	44	54			01,02										Vb 17	CASTSGRERSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCATCTCAATAGGGGATGGTGCGCAGTATTTTGGCCCA	CAISIGDGAQYF	In	VDJ	1	13	0.0013445030509876927	0.0017536759746391475	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	10	5	2	10	7	6	27	34	46	41	52			01,02										Vb 17	CAISIGDGAQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCCGAAATCAGGAAGAGACCCAGTACTTCGGGCCA	CATRNQEETQYF	In	VDJ	1	16	0.0016547729858310063	0.0021583704303251047	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	10	4	4	3	8	0	27	34	-1	42	46			01,02										Vb 17	CATRNQEETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAGAAAGGCGGGAGTAGCACAGATACGCAGTATTTTGGCCCA	CASKKGGSSTDTQYF	In	VDJ	1	19	0.00196504292067432	0.0025630648860110617	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	7	2	0	6	1	27	37	50	43	51			01,02										Vb 17	CASKKGGSSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCGGGACAGGGGCCGCCCGGTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	20	0.002068466232288758		53	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	2	0	2	8	27	40	52	42	60			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGGGTTAAGCAAATCGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	21	0.0021718895439031957		50	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	5	6	2	4	0	18	27	-1	43	39	61			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCGGGGACAGCAATCAGCCCCAGCATTTTGGTGAT	CASSTGDSNQPQHF	In	VDJ	1	23	0.0023787361671320714	0.003102657493592338	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	4	0	7	1	3	0	27	40	-1	43	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSTGDSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGTGGGACAGGGAGGATGGCTACACCTTCGGTTCG	CASSMWDREDGYTF	In	VDJ	2	85	0.00879098148722722	0.011466342911102118	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	3	6	2	3	27	41	52	43	55			01,02										Vb 17	CASSMWDREDGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGTCATAGTGAAAAACTGTTTTTTGGCAGT	CASGHSEKLFF	In	VDJ	2	96	0.009928637914986037	0.012950222581950627	33	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	8	5	8	7	5	0	27	36	-1	41	44			01,02			01,02							Vb 17	CASGHSEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01	TCRBJ01-04*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCGGATTTGCCGGTAGCGGGAGATCAGATACGCAGTATTTTGGCCCA	CASSAGFAGSGRSDTQYF	In	VDJ	15	613	0.06339849001965044	0.08269256711183057	54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	5	2	4	14	2	27	39	62	53	64			01,02										Vb 17	CASSAGFAGSGRSDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCACCAGACAGGGGGCCGGGGAGCTGTTTTTTGGAGAA	CASTRQGAGELFF	In	VDJ	1	32	0.0033095459716620127	0.004316740860650209	39	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	2	1	6	3	0	23	33	-1	36	45													Vb 11	CASTRQGAGELFF+TCRBV25-01+TCRBJ02-02	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-02*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAGGCAGATTGAACACTGAAGCTTTCTTTGGACAA	CASSEGRLNTEAFF	In	VDJ	4	175	0.01809907953252663	0.023607176581680833	42	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	5	0	2	2	23	38	43	40	45													Vb 11	CASSEGRLNTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTAGGGGACACCTCAGATACGCAGTATTTTGGCCCA	CASSLGDTSDTQYF	In	VDJ	1	28	0.002895852725204261	0.003777148253068933	42	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	0	6	4	0	3	19	-1	41	35	44														CASSLGDTSDTQYF+TCRBV07-07+TCRBJ02-03	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-03*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
GACGCAGCCATGTACCTGTGTGCCACCAGGACTAGCGGGAGCATCAATGAGCAGTTCTTCGGGCCA	CATRTSGSINEQFF	In	VDJ	1	37	0.003826662529734202	0.0049912316201268046	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	2	2	6	0	3	18	-1	41	29	44														CATRTSGSINEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01*02	TCRBJ02-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCATTCGGGCAGGGGCAGGCGAGCAGTACTTCGGGCCG	CATSIRAGAGEQYF	In	VDJ	1	46	0.004757472334264143	0.006205314987184676	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	2	6	6	4	18	31	43	37	47														CATSIRAGAGEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-07*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCATAGACAGCGGTCAGAGGCCCCAGCATTTTGGTGAT	CATSIDSGQRPQHF	In	VDJ	1	54	0.005584858827179647	0.007284500202347228	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	6	5	9	1	6	18	35	41	36	47						01,02								CATSIDSGQRPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD02-01	TCRBJ01-05*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGTGGGGGAAAACACTGAAGCTTTCTTTGGACAA	CATSRVGENTEAFF	In	VDJ	8	329	0.034026269521150065	0.044381491973559964	42	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-01	01	1	6	1	2	1	2	18	34	40	35	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRVGENTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01		TCRBJ01-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAAGGGGAAAAACACTGAAGCTTTCTTTGGACAA	CASKGKNTEAFF	In	VDJ	1	12	0.0012410797393732546	0.0016187778227438284	36				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	5	2	2	0	3	24	-1	39	34	42	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASKGKNTEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCACCAGTGACCCGACTAGTAGCACAGATACGCAGTATTTTGGCCCA	CATSDPTSSTDTQYF	In	VDJ	1	12	0.0012410797393732546	0.0016187778227438284	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	2	8	0	5	1	23	35	46	40	47	TCRBV24,TCRBV27					01,02								CATSDPTSSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCTCCCACCGGGACAGGGAAAACTGAAGCTTTCTTTGGACAA	CATSDSPTGTGKTEAFF	In	VDJ	1	12	0.0012410797393732546	0.0016187778227438284	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	0	3	5	8	3	24	40	57	48	60		TCRBV24-01,TCRBV24-or09_02												CATSDSPTGTGKTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CCCTGAAGACWSSRSCMTRTATCTCTGCGCCAGCAGCCAAGTAACTAGCACAGATACGCAGTATTTTGGCCCA	CASSQVTSTDTQYF	In	VDJ	1	12	0.0012410797393732546	0.0016187778227438284	42	unresolved			unresolved			TCRBJ02	TCRBJ02-03	01	11	4	5	0	2	13	25	28	33	30	46	TCRBV04,TCRBV29			TCRBD01,TCRBD02										CASSQVTSTDTQYF+X+TCRBJ02-03	unresolved	unresolved	TCRBJ02-03*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCTGGTCGGACAGCGAAGAGACCCAGTACTTCGGGCCA	CASSWSDSEETQYF	In	VDJ	1	12	0.0012410797393732546	0.0016187778227438284	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	1	5	3	4	2	19	32	42	36	44	TCRBV05,TCRBV07													CASSWSDSEETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
GGACTCGGCCMTGTATCTCTGTGCCAGCAGCCAGCAAACGACGGTTCATCTGAGGGCTTCCAACAATGAGCAGTTCTTCGGGCCA	CASSQQTTVHLRASNNEQFF	In	VDJ	1	12	0.0012410797393732546	0.0016187778227438284	60	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	11	0	5	20	6	19	31	56	51	62	TCRBV05,TCRBV07,TCRBV11													CASSQQTTVHLRASNNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
TGGGRGACWCRGCWYTGTATYTCTGYGCCAGCAGCCCCGTGTCCCAAGAGACCCAGTACTTCGGGCCA	CASSPVSQETQYF	In	VDJ	1	12	0.0012410797393732546	0.0016187778227438284	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	8	6	1	2	4	23	35	39	37	43	TCRBV09,TCRBV23					01,02								CASSPVSQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGACAGGGTGTTTGGACCGGGGAGCTGTTTTTTGGAGAA	CASSLGQGVWTGELFF	In	VDJ	1	13	0.0013445030509876927	0.0017536759746391475	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	2	3	5	0	7	26	-1	49	42	56		TCRBV12-03,TCRBV12-04												CASSLGQGVWTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTCAGCCGGGACAGGGAGACACTGAAGCTTTCTTTGGACAA	CASSQPGQGDTEAFF	In	VDJ	1	13	0.0013445030509876927	0.0017536759746391475	45				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	3	3	5	2	24	36	50	41	52	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASSQPGQGDTEAFF+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCAACCAGGGGACTAGCGGGACTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	13	0.0013445030509876927		53	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	0	3	4	7	2	24	40	60	47	62		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*02	TCRBJ02-07*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CACCWMMCAKACMTCTMWGTACCTCTGTGCCAGCAGGCGATCCAGGGTCTCCGAGCAGTACTTCGGGCCG	CASRRSRVSEQYF	In	VDJ	1	14	0.0014479263626021306	0.0018885741265344666	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	3	6	6	4	23	34	45	40	49	TCRBV25,TCRBV28													CASRRSRVSEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
GGACTCRGCCATGTATCKCTGTGCCAGCAGCGCCCGGGATAGGGGGCTTTGGCAGCCCCAGCATTTTGGTGAT	CASSARDRGLWQPQHF	In	VDJ	1	14	0.0014479263626021306	0.0018885741265344666	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	5	0	7	9	5	19	31	47	40	52	TCRBV07,TCRBV11													CASSARDRGLWQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGACCTAGACAGGGGTTATGGCTACACCTTCGGTTCG	CSDLDRGYGYTF	In	VDJ	1	15	0.0015513496742165685	0.0020234722784297854	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	2	2	5	5	1	26	33	46	38	47		TCRBV20-01,TCRBV20-or09_02												CSDLDRGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCACCGACAGGGGGACGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	15	0.0015513496742165685		49	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	11	2	1	0	5	3	24	31	45	36	48		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-06	TCRBV24	TCRBD01-01*01	TCRBJ02-06*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCGACTAGCGGGAGGGGCAGATACGCAGTATTTTGGCCCA	CASSRLAGGADTQYF	In	VDJ	1	16	0.0016547729858310063	0.0021583704303251047	45	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	2	0	4	1	1	26	38	53	39	54		TCRBV12-03,TCRBV12-04												CASSRLAGGADTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACCCCCGGGAGACCCAGTACTTCGGGCCA	CSANPRETQYF	In	VDJ	1	17	0.0017581962974454442	0.0022932685822204236	33	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	8	5	5	5	0	26	36	-1	41	44		TCRBV20-01,TCRBV20-or09_02				01,02								CSANPRETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCCGGACTAGCGGGAGGCCAACCTACAATGAGCAGTTCTTCGGGCCA	CSATRTSGRPTYNEQFF	In	VDJ	1	17	0.0017581962974454442	0.0022932685822204236	51	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	1	1	2	3	4	26	36	53	39	57		TCRBV20-01,TCRBV20-or09_02												CSATRTSGRPTYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCTGGTCGGACGGCAAAGAGACCCAGTACTTCGGGCCA	CASSWSDGKETQYF	In	VDJ	1	19	0.00196504292067432	0.0025630648860110617	42	unresolved						TCRBJ02	TCRBJ02-05	01	6	1	7	3	6	4	26	37	47	43	51	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWSDGKETQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCCCCAGGATCAGGGTGGGTCCTTTTCTATGGCTACACCTTCGGTTCG	CSASPGSGWVLFYGYTF	In	VDJ	1	20	0.002068466232288758	0.0026979630379063806	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	3	4	10	11	26	35	50	45	61		TCRBV20-01,TCRBV20-or09_02												CSASPGSGWVLFYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
AGCCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTTTTCCCGAGGGGGCCGCGAAAAGAAGCTTTCTTTGGACAA		Out	VDJ	1	21	0.0021718895439031957		46				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	5	0	8	5	8	35	49	61	54	69	TCRBV27,TCRBV28	TCRBV27-01,TCRBV28-01												X+X+TCRBJ01-01		TCRBD01-01*01	TCRBJ01-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCCAGGGGGGTTCTGGAAACACCATATATTTTGGAGAG	CASSQGGSGNTIYF	In	VDJ	1	21	0.0021718895439031957	0.0028328611898017	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	4	1	1	0	2	19	-1	38	31	40	TCRBV07,TCRBV11													CASSQGGSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTAGAGGACTAGCGGGAGATTACAATGAGCAGTTCTTCGGGCCA	CSRGLAGDYNEQFF	In	VDJ	1	22	0.0022753128555176336	0.0029677593416970187	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	8	1	2	4	3	2	26	32	48	35	50		TCRBV20-01,TCRBV20-or09_02												CSRGLAGDYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAACTCGGGACAGGGGGCACAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	23	0.0023787361671320714		46	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	12	0	0	3	9	1	26	31	52	40	53	TCRBV12,TCRBV21													X+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTCTTAAAAACGGGACAGGTTAGCAATCAGCCCCAGCATTTTGGTGAT	CSARVLKTGQVSNQPQHF	In	VDJ	1	23	0.0023787361671320714	0.003102657493592338	54	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	0	4	0	10	1	26	39	57	49	58		TCRBV20-01,TCRBV20-or09_02												CSARVLKTGQVSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
AGCACCAACCAGACATCTRTGTAYCTCTRTGCCAGCAGTTTAAATGTTGGGGAGGGTCACACTGAAGCTTTCTTTGGACAA	XASSLNVGEGHTEAFF	In	VDJ	1	23	0.0023787361671320714	0.003102657493592338	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	9	0	3	7	2	25	40	54	47	56	TCRBV26,TCRBV28													XASSLNVGEGHTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGGCCCTTTTGGCTGAAAGACCTATGGCTACACCTTCGGTTCG	CASSGPFG*KTYGYTF	Stop	VDJ	1	23	0.0023787361671320714		48	TCRBV24						TCRBJ01	TCRBJ01-02	01	5	2	7	4	16	0	24	37	-1	53	56		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGPFG*KTYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
AACCCAGSGACTCRGCTGTGTATYTYTGTGCCAGCAGCTTCGGCAGGGGGTCAGATACGCAGTATTTTGGCCCA	CASSFGRGSDTQYF	In	VDJ	1	23	0.0023787361671320714	0.003102657493592338	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	1	4	3	1	19	33	43	36	44	TCRBV07,TCRBV12													CASSFGRGSDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCGACACCGGGGAGCTGTTTTTTGGAGAA	CASSPDTGELFF	In	VDJ	1	24	0.0024821594787465093	0.003237555645487657	36	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	5	8	6	3	2	0	26	38	-1	40	42		TCRBV12-03,TCRBV12-04				01,02								CASSPDTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01	TCRBJ02-02*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGTTCGACGGCTAACACTGAAGCTTTCTTTGGACAA	CASSTANTEAFF	In	VDJ	1	25	0.002585582790360947	0.0033724537973829757	36	TCRBV24						TCRBJ01	TCRBJ01-01	01	11	2	7	2	4	4	24	31	38	35	42		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTANTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGTAGCGGCGAGTGGCACGAGCAGTACTTCGGGCCG		Out	VDJ	1	26	0.0026890061019753855		41	unresolved			unresolved			TCRBJ02	TCRBJ02-07	01	6	5	5	5	2	8	26	37	45	39	53	TCRBV09,TCRBV12			TCRBD01,TCRBD02										X+X+TCRBJ02-07	unresolved	unresolved	TCRBJ02-07*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCGCGGGGGCCCTCTACGAGCAGTACTTCGGGCCG	CSAPAGALYEQYF	In	VDJ	1	26	0.0026890061019753855	0.003507351949278295	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	7	2	3	3	4	26	35	45	38	49		TCRBV20-01,TCRBV20-or09_02												CSAPAGALYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAACCGGGGTCAGATAAGCAGTACTTCGGGCCG	CASSQPGSDKQYF	In	VDJ	1	28	0.002895852725204261	0.003777148253068933	39	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	2	8	3	8	1	7	26	41	47	42	54		TCRBV03-01,TCRBV03-02												CASSQPGSDKQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*01	TCRBJ02-07*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CCACGTTTGGTGCCAGCCAGACCTCTGTACCTCTGTGCCAGCAGTCAAATGCAGGGTATAGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSQMQGIGTGELFF	In	VDJ	1	30	0.003102699348433137	0.004046944556859571	48				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	3	4	6	6	33	45	56	51	62	TCRBV25,TCRBV27,TCRBV28	TCRBV25-01,TCRBV25-or09_02,TCRBV27-01,TCRBV28-01												CASSQMQGIGTGELFF+X+TCRBJ02-02		TCRBD01-01*01	TCRBJ02-02*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGTACGGGACGGAGAGTCCACGAGCAGTACTTCGGGCCG		Out	VDJ	1	30	0.003102699348433137		49	TCRBV24						TCRBJ02	TCRBJ02-07	01	0	0	7	5	3	9	24	42	50	45	59		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTAATGTTATCCCATTGCAAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	32	0.0033095459716620127		46	TCRBV03						TCRBJ02	TCRBJ02-03	01	5	4	6	5	11	5	26	38	51	49	56		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGAGCGGGAGTACGAGCAGTACTTCGGGCCG	CSAREREYEQYF	In	VDJ	1	32	0.0033095459716620127	0.004316740860650209	36	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	6	2	4	2	0	26	37	-1	39	47		TCRBV20-01,TCRBV20-or09_02												CSAREREYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCGTCCAGGGGGCCGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSVQGAGTGELFF	In	VDJ	1	32	0.0033095459716620127	0.004316740860650209	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	0	5	4	4	22	33	45	37	49		TCRBV12-03,TCRBV12-04												CASSVQGAGTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD01-01*01	TCRBJ02-02*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAATAGGGGGGGCGTTGGCTTTCTTTGGACAA	CASSLIGGALAFF	In	VDJ	1	32	0.0033095459716620127	0.004316740860650209	39	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	9	0	11	6	5	24	36	49	42	54		TCRBV24-01,TCRBV24-or09_02												CASSLIGGALAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01*01	TCRBJ01-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCGCCTCCACCCCGTAAGGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	33	0.0034129692832764505		38	TCRBV24						TCRBJ02	TCRBJ02-07	01	12	5	4	4	14	0	24	30	-1	44	47		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATCGGGACTTATCCTACAATGAGCAGTTCTTCGGGCCA	CASSQDRDLSYNEQFF	In	VDJ	1	35	0.0036198159065053263	0.004721435316336166	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	0	10	1	2	2	23	40	48	42	50	TCRBV01,TCRBV04					01,02								CASSQDRDLSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCCCTGGACAGGGAGAAAAACTGTTTTTTGGCAGT	CASSPGQGEKLFF	In	VDJ	1	38	0.00393008584134864	0.005126129772022123	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	1	3	8	3	1	23	35	46	38	47	TCRBV09,TCRBV21													CASSPGQGEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGAGCCGATATACAGGGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	41	0.004240355776191954		41	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	9	3	3	4	9	2	23	31	46	40	48	TCRBV06,TCRBV10													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGCAAACAGGGGGCTGGAAACACCATATATTTTGGAGAG	CARSKQGAGNTIYF	In	VDJ	1	41	0.004240355776191954	0.00553082422770808	42				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	3	1	2	2	0	18	30	-1	32	40	TCRBV05,TCRBV11	TCRBV05-03,TCRBV11-03												CARSKQGAGNTIYF+X+TCRBJ01-03		TCRBD01-01*01	TCRBJ01-03*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAATCGTCTGGGGTATTGGTGACCCCAGCATTTTGGTGAT	CNRLGYW*PQHF	Stop	VDJ	1	42	0.004343779087806391		36	TCRBV20						TCRBJ01	TCRBJ01-05	01	10	6	2	10	7	9	26	30	41	37	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CNRLGYW*PQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCATGGACCAACCTCCAGGAGCAGTACTTCGGGCCG	CSARPWTNLQEQYF	In	VDJ	1	42	0.004343779087806391	0.0056657223796034	42	TCRBV20						TCRBJ02	TCRBJ02-07	01	2	1	7	7	4	10	26	38	46	42	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARPWTNLQEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20		TCRBJ02-07*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAACTAGCGGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CSARELAGAYNEQFF	In	VDJ	1	43	0.00444720239942083	0.0058006205314987186	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	3	2	2	0	0	26	-1	-1	40	51		TCRBV20-01,TCRBV20-or09_02												CSARELAGAYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
GACTCGGCCGTGTATGTCTGTGCCAGAAGTATTCAGTGGTAGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	46	0.004757472334264143		52				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	6	5	12	5	18	29	45	41	50	TCRBV05,TCRBV11,TCRBV12	TCRBV05-03,TCRBV11-03,TCRBV12-02												X+X+TCRBJ02-06		TCRBD01-01*01	TCRBJ02-06*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGGACAGGCTTCCATTTCGTGTTAGACGAGCAGTACTTCGGGCCG		Out	VDJ	1	47	0.004860895645878581		50	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	4	5	0	17	26	-1	45	38	62		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATCGGGGCAGGGGTCTAATAATGAGCAGTTCTTCGGGCCA	CSARSGQGSNNEQFF	In	VDJ	1	47	0.004860895645878581	0.006340213139079995	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	2	7	6	6	26	38	50	44	56		TCRBV20-01,TCRBV20-or09_02												CSARSGQGSNNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTCAGGGCTACCCAAGAGACCCAGTACTTCGGGCCA	CSALRATQETQYF	In	VDJ	1	50	0.005171165580721894	0.006744907594765951	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	4	3	1	2	4	26	35	42	37	46		TCRBV20-01,TCRBV20-or09_02												CSALRATQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGTACACATTCCATTTGCAAAGAAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	53	0.005481435515565208		52	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	3	6	4	2	17	26	38	43	40	60		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD01-01*01	TCRBJ02-04*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTAACATGCCATTTTTGGCATCATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	54	0.005584858827179647		50	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	6	5	2	16	26	38	43	40	59		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTCATACATCATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	2	67	0.0069293618781673385		47	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	3	6	5	5	2	26	43	51	48	53		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD01-01*01	TCRBJ01-06*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCCCCGACAGGCTCCTAACTATGGCTACACCTTCGGTTCG	CSASPRQAPNYGYTF	In	VDJ	2	89	0.009204674733684973	0.012005935518683394	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	4	0	5	3	26	37	48	42	51		TCRBV20-01,TCRBV20-or09_02												CSASPRQAPNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGTAATTGCTCCATTTGTCATGCAAGATACGCAGTATTTTGGCCCA	CASSVIAPFVMQDTQYF	In	VDJ	2	95	0.0098252146033716	0.012815324430055309	51	TCRBV03						TCRBJ02	TCRBJ02-03	01	5	4	6	5	10	11	26	38	50	48	61		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVIAPFVMQDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAGGGACTAGCGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSAGTSGSSYNEQFF	In	VDJ	2	96	0.009928637914986037	0.012950222581950627	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	0	2	0	1	0	26	34	-1	35	49		TCRBV20-01,TCRBV20-or09_02												CSAGTSGSSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
GAGACWCGGCMSTGTATCTCTGYGCCAGCAGCTTATGGCCTAGCAGTGAGCAGTTCTTCGGGCCA	CASSLWPSSEQFF	In	VDJ	2	100	0.010342331161443789	0.013489815189531903	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	4	7	9	8	2	20	31	44	39	46	TCRBV07,TCRBV23					01,02								CASSLWPSSEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACTCAGGGGGAGAGACCCAGTACTTCGGGCCA	CASSHSGGETQYF	In	VDJ	3	108	0.011169717654359293	0.014569000404694455	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	1	4	2	0	26	40	-1	42	49		TCRBV03-01,TCRBV03-02												CASSHSGGETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAATCCGGGACAGGGGATTTCCTACGAGCAGTACTTCGGGCCG	CASSNPGQGISYEQYF	In	VDJ	4	151	0.015616920053780122	0.020369620936193173	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	2	1	5	3	26	38	53	43	56		TCRBV03-01,TCRBV03-02												CASSNPGQGISYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGATGTACCTCCATTTACACGCACGAAACACCATATATTTTGGAGAG		Out	VDJ	4	172	0.01778880959768332		52	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	3	6	5	15	5	26	38	56	53	61		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD01-01*01	TCRBJ01-03*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTTCCCGAGGGGGCCGCGAAAAGAAGCTTTCTTTGGACAA		Out	VDJ	9	358	0.03702554555796877		46	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	5	0	8	7	8	24	36	50	43	58		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTATCATTGGCACAGATACGCAGTATTTTGGCCCA	CSASIIGTDTQYF	In	VDJ	10	418	0.04323094425483504	0.056387427492243354	39	TCRBV20						TCRBJ02	TCRBJ02-03	01	3	4	6	1	3	3	26	37	42	40	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASIIGTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTTACTGCAGGGGGCATTGTTACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	55	0.005688282138794084		53	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	3	4	0	3	5	6	18	32	45	37	51														X+TCRBV07-02+TCRBJ02-02	TCRBV07-02*01	TCRBD01-01*01	TCRBJ02-02*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCCCTCAGGGTACTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPQGTGANVLTF	In	VDJ	1	16	0.0016547729858310063	0.0021583704303251047	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	4	3	2	3	2	18	30	38	33	40														CASSPQGTGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCTGGATTAAATCTCACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	27	0.0027924294135898233		56	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	3	1	8	5	2	17	18	32	37	34	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGGGGATTCTCGCTACAATGAGCAGTTCTTCGGGCCA	CASSLGDSRYNEQFF	In	VDJ	1	28	0.002895852725204261	0.003777148253068933	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	3	6	1	3	0	7	18	-1	37	32	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGDSRYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGCCGGGACAGGGGAACACTGAAGCTTTCTTTGGACAA	CASSSPGQGNTEAFF	In	VDJ	1	34	0.0035163925948908884	0.004586537164440847	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	0	3	1	4	0	18	31	-1	35	44														CASSSPGQGNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
GACTCGGCCGTGTATGTCTGTGCCAGCCAGCCCCGGGATGGGTCAACCGGGGAGCTGTTTTTTGGAGAA	CASQPRDGSTGELFF	In	VDJ	1	45	0.004654049022649705	0.006070416835289356	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	8	8	3	5	6	7	18	27	38	33	45														CASQPRDGSTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-02*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATCCAGCCTGCTCTTAATGAGCAGTTCTTCGGGCCA	CASSLIQPALNEQFF	In	VDJ	2	67	0.0069293618781673385	0.009038176176986375	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-01	01	2	4	5	7	3	9	18	33	39	36	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLIQPALNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01		TCRBJ02-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGCTGAGCGGGCACATAGGCTAACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLG*AGT*ANSYNEQFF	Stop	VDJ	2	69	0.007136208501396215		60	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	6	4	0	4	12	18	34	44	38	56						01,02								CASSLG*AGT*ANSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGCCACAGGTTCTGGCACTGAAGCTTTCTTTGGACAA	CASSATGSGTEAFF	In	VDJ	2	76	0.00786017168269728	0.010252259544044247	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	4	4	3	6	18	30	38	33	44														CASSATGSGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTACAGACAGGGTTCAACAATGAGCAGTTCTTCGGGCCA	CASSLVQTGFNNEQFF	In	VDJ	3	115	0.011893680835660357	0.015513287467961689	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	2	3	5	4	4	18	34	45	38	49														CASSLVQTGFNNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGACAGGCTTCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	5	210	0.02171889543903196		43	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	4	1	0	3	18	-1	39	35	42														X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGGGACAGGTATCTACGAGCAGTACTTCGGGCCG	CASSSGTGIYEQYF	In	VDJ	5	228	0.02358051504809184	0.03075677863213274	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	4	3	2	3	18	31	41	33	44														CASSSGTGIYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTTGAGTCGGGGATTCCGTTTTACGAGCAGTACTTCGGGCCG	CASSLVESGIPFYEQYF	In	VDJ	10	417	0.0431275209432206	0.05625252934034804	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	8	3	4	6	9	18	34	45	40	54														CASSLVESGIPFYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCGAAGCAAGAGACACCGGGGAGCTGTTTTTTGGAGAA	CAEARDTGELFF	In	VDJ	1	28	0.002895852725204261	0.003777148253068933	36	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	12	6	7	3	3	5	26	31	37	34	42						01,02								CAEARDTGELFF+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01	TCRBD02-01	TCRBJ02-02*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGTCAGGGCTGTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	28	0.002895852725204261		41	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	3	3	1	4	26	41	47	42	51														X+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-07*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCATGACAGGTTGGTCTACGAGCAGTACTTCGGGCCG	CASSHDRLVYEQYF	In	VDJ	1	34	0.0035163925948908884	0.004586537164440847	42	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	4	3	1	5	20	34	41	35	46														CASSHDRLVYEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAAATATCGCAGGCCGGGGAGCTGTTTTTTGGAGAA	CASKISQAGELFF	In	VDJ	1	13	0.0013445030509876927	0.0017536759746391475	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	4	4	6	8	0	23	33	-1	41	45														CASKISQAGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCTTGGACAGGGGTATGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	16	0.0016547729858310063		41	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	10	1	2	3	4	2	23	30	43	34	45														X+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTTAGGAACCAGGGAGACCCAGTACTTCGGGCCA	CASSYLGTRETQYF	In	VDJ	1	24	0.0024821594787465093	0.003237555645487657	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	4	4	5	7	0	23	39	-1	46	50														CASSYLGTRETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTATACCGTTCTGCAGCATCGGAAAGACCTATGGCTACACCTTCGGTTCG	CASSIPFCSIGKTYGYTF	In	VDJ	1	50	0.005171165580721894	0.006744907594765951	54	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	5	1	8	4	18	5	23	35	56	53	61				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSIPFCSIGKTYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAGCGCCGGGGAGCTGTTTTTTGGAGAA	CASSYSSAGELFF	In	VDJ	2	65	0.006722515254938463	0.008768379873195738	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	6	6	6	1	0	23	40	-1	41	45						01,02								CASSYSSAGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACGGGGCCTACGAGCAGTACTTCGGGCCG	CASSDGAYEQYF	In	VDJ	2	67	0.0069293618781673385	0.009038176176986375	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	3	2	2	0	23	35	-1	37	42														CASSDGAYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCCGGTCCGGGAGACTGGAAACACCATATATTTTGGAGAG	CASSPVRETGNTIYF	In	VDJ	1	47	0.004860895645878581	0.006340213139079995	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	6	8	2	2	7	1	24	35	48	42	49													Vb 18	CASSPVRETGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-03*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGACAGGCCGTGATGGCTACACCTTCGGTTCG	CASSPTGRDGYTF	In	VDJ	1	48	0.004964318957493019	0.006475111290975314	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	2	4	6	0	5	24	-1	44	38	49													Vb 18	CASSPTGRDGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	2568A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				271	207	59	3	0	143	108	32	3	0	9669	7413	2122	134	0	0.172511414	5.58959246	0.147398427	6.10451746				2640	0.0821839795	0.133684069	0.102492504	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:37:52	Age (Range):65+ Years (Old Age),Age:65 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1238,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 330,type of chemo:carbo/taxol	0.7638376175569029	MSKCC- Snyder- P01-02		217.0	
